Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Cost Avoidance vs Cost Savings: What’s the Difference?
By Jennifer Dawson, MHA, DLM (ASCP) bio
As I work to spread awareness within the clinical laboratory community about the Cost of Poor Quality (COPQ) concept and its benefits as a method to demonstrate…
Targeted Sequencing Panel May Aid Diagnosis of Movement Disorders
...
Already a member? Log in here
FDA Issues Warning for ‘Over Reliance’ on Rupture of Membrane Tests
...
Already a member? Log in here
Mailed Kits Can Up Colorectal Screening at Community Health Clinics
...
Already a member? Log in here
With New FDA Input, Momentum for LDT Regulation Accelerating
...
Already a member? Log in here
High-Sensitivity Troponin Test Rules Out Heart Attacks Faster
From - Diagnostic Testing & Emerging Technologies
Use of a high-sensitivity cardiac troponin test (hs-cTnT) may be able to more quickly determine whether emergency department patients are having…
Whole-Genome Sequencing Adds Value to Cardiomyopathy Workup
From - Diagnostic Testing & Emerging Technologies
Whole-genome sequencing (WGS) identifies additional genetic causes of hypertrophic cardiomyopathy (HCM) beyond those identified through targeted…
Noninvasive Gene Expression Test for Melanoma Cuts Costs
From - Diagnostic Testing & Emerging Technologies
The noninvasive pigmented lesion assay (PLA; DermTech) reduces costs compared to the current standard of care for diagnostic workup of pigmented skin lesions suggestive of…
Next-Gen Sequencing Has Significant Utility for Drug-Resistant Epilepsy
From - Diagnostic Testing & Emerging Technologies
Next-generation sequencing improves definitive diagnoses for children with drug-resistant epilepsy, according to a pilot study published online…
General Population Has Interest in Genetic Testing for Skin Cancer Risk
...
Already a member? Log in here
